Compare Humana Inc (HUM) vs Lockheed Martin Corporation (LMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Lockheed Martin Corporation — how do they compare? Humana Inc trades at $450.06 (market cap $46.49B), while Lockheed Martin Corporation trades at $506.8 (market cap $117.22B). The key difference: Lockheed Martin Corporation is far larger — about 2.5× Humana Inc's market cap, and Lockheed Martin Corporation pays the higher dividend (2.72%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Lockheed Martin Corporation for 86 Days on average.
| HUM | LMT | |
|---|---|---|
Market Cap | $46.49B | $117.22B |
Volume | 2,567,704 | 1,101,121 |
Sector | Health | Industrials |
52-Week High | $409.85 | $676.70 |
52-Week Low | $163.67 | $439.19 |
Typical Hold Time | 53 Days | 86 Days |
Enterprise Value | $53.84B | $133.96B |
Dividend Yield | 0.91% | 2.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
Lockheed Martin (LMT) trades at $499.22, down 2.14% on the day, amid a bearish technical signal and recent earnings volatility. The company reported revenue growth to $75.05B in 2025, but net income margin declined to 6.68%. Analyst consensus remains bullish with a $635.33 price target, supported by strong defense spending trends and a 23-year dividend growth streak. Recent news highlights AI integration and F-35 program developments, though fixed-price contract risks persist.
LMT offers value with a P/E of 18.41 and robust cash flow, but faces execution risks from contract missteps and debt levels near 36% of assets. Upside hinges on defense budget continuity and operational efficiency, while margin pressure and competitive threats from peers like Boeing pose challenges. The stock's current discount to analyst targets presents a potential entry point for long-term investors, balanced by near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Lockheed Martin Corporation
Lockheed Martin is the largest defense contractor globally and has dominated the Western market for high-end fighter aircraft since the F-35 program was awarded in 2001. Lockheed's largest segment is aeronautics, which is dominated by the massive F-35 program. Lockheed's remaining segments are rotary and mission systems, which is mainly the Sikorsky helicopter business.
Read more on LMT →
